This company gets such little credit for their incredible financial discipline.
Our corporate and administrative costs went down in 2024 compared to 2023 to 4.7m. That essentially everything that isn't directly R&D which is incredible. That FX windfall has paid for 2024's operating costs 5 times over!
Our R&D spend has increased as expected (and will continue to do so for the Phase 3 costs) but this exactly what we want to see, not to mention there are tax rebates for R&D spend here in Australia. There are so many companies that have huge growth in operating costs as revenue grows, not Neuren.
Incredible work!
Ann: Appendix 4E and 2024 full year accounts, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.10 |
Change
-0.800(5.76%) |
Mkt cap ! $1.629B | |||
| Open | High | Low | Value | Volume |
| $13.95 | $13.96 | $12.88 | $9.534M | 725.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 266 | $13.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.15 | 1619 | 2 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |